Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Levosulpiride (150mg) Tablet
Therapeutic Category
Gastroenterology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Lesutype 150 Tablet containing Levosulpiride is used for the management of gastrointestinal motility disorders and functional digestive conditions. It helps improve gastric emptying, reduce digestive discomfort, and support healthy gastrointestinal function.
Levosulpiride works as a selective dopamine D2 receptor antagonist that enhances gastrointestinal motility and promotes coordinated digestive tract movement, helping improve symptoms associated with dyspepsia and delayed gastric emptying.
The tablet is widely prescribed in gastroenterology and general medicine practice for functional dyspepsia, gastroesophageal reflux-related symptoms, and other digestive motility disorders, leading to consistent prescription demand.
With increasing prevalence of digestive disorders and growing demand for effective gastroprokinetic therapies, this product offers strong business potential for retailers and distributors. Its established therapeutic efficacy, broad clinical relevance, and steady market demand make it a reliable product for growth in the gastro care segment.
Some patients may experience drowsiness, dizziness, headache, nausea, abdominal pain, constipation, or diarrhea. Rarely, hormonal disturbances such as increased prolactin levels, menstrual irregularities, breast tenderness, extrapyramidal symptoms, or allergic reactions may occur and require medical attention.
Lesutype 150 Tablet is indicated for gastroesophageal reflux disease (GERD), functional dyspepsia, indigestion, bloating, nausea, delayed gastric emptying (gastroparesis), and other gastrointestinal motility disorders. It helps relieve symptoms such as abdominal discomfort, fullness, heartburn, and digestive disturbances.
This medicine should be used strictly under medical supervision. Use cautiously in patients with epilepsy, Parkinson’s disease, kidney impairment, or hormonal disorders. Avoid activities requiring alertness if drowsiness or dizziness occurs. Follow the prescribed dosage and duration of therapy carefully.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Levosulpiride (25mg) Tablet
Composition : Levosulpiride (75mg) + Pantoprazole (40mg)
Composition : Levosulpiride (75mg) + Rabeprazole (20mg)
Composition : Rabeprazole 40mg (EC) + Domperidone 30mg (SR) Capsule
Composition : Levosulpiride (75mg) + Esomeprazole (40mg)
Composition : Pantoprazole (80mg) Dual Release Gastro-Resistant
Composition : Pachak Syrup
Composition : Domperidone I.P. 10mg + Paracetamol I.P. 325mg
Composition : Sodium Picosulfate B.P. 5mg Solution
Composition : SODIUM PICOSULFATE 3.33MG + LIQUID PARAFFIN 1.25 ML + MILK OF MAGNESIA 3.75 ML SUGAR FREE
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Levosulpiride 150 mg Tablet is used for gastrointestinal motility disorders such as functional dyspepsia, bloating, nausea, vomiting, and acid-related gastric issues. It is a strong gastroenterology and prokinetic segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in gastro clinics, general physician prescriptions, and hospital outpatient departments. It is widely used for digestive motility and upper GI disorders, ensuring steady prescription-based sales and repeat demand.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for gastro and prokinetic formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong prescription flow, chronic digestive disorder management demand, and steady retail movement in gastroenterology segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this gastro formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.